Cord blood bilirubin level as an early predictor of neonatal hyperbilirubinemia - A hospital-based prospective study

Vikram Singhal, Nutan Kamath, B. S. Baliga, B. Unnikrishnan

Research output: Contribution to journalArticle

Abstract

Background: Neonatal hyperbilirubinemia, a condition characterized by elevated bilirubin level in blood, is a common, complicated, and controversial clinical problem. The American Academy of Pediatrics (AAP) recommends a follow-up visit, after 2 to 3 days of birth, to detect significant jaundice in all newborns discharged within 48 hours of delivery. The present study was carried out to evaluate cord blood bilirubin levels as an early predictor of neonatal hyperbilirubinemia. Methods: The study group consisted of 500 term, appropriate for gestational age (AGA) neonates with an Apgar score of ≥7. Total bilirubin of ≥15 mg/dL was defined as significant hyperbilirubinemia. Umbilical cord serum bilirubin (UCSB) was estimated and followed up daily for evidence of neonatal hyperbilirubinemia up to 5 postnatal days. Prevalence of hyperbilirubinemia was found to be 14% in the study population. In case of clinical jaundice presenting before 5 days, serum bilirubin level was estimated on the day of detection. Values of bilirubin on fifth day were related with that of cord blood bilirubin. Blood groups of both mothers and newborns were evaluated. Direct Coomb's test was done in presence of ABO incompatibility. Data were analyzed using chi-square, and receiver operating characteristics (ROC) curve. Results: Mean UCSB was reported to be 1.56 ± 0.70 mg/dL. There was a significant association between route of delivery, birth order, and hyperbilirubinemia requiring phototherapy (P<.005). Using UCSB level of 31.9 mg/dL, hyperbilirubinemia could be predicted with sensitivity of 90% and specificity of 82.55% and positive predictive value of 45.65% and negative predictive value of 98.07%. There was no significant association found between the mothers' blood groups and increased risk of hyperbilirubinemia in neonates in this study. Conclusion: This study suggests that the measurement of UCSB is a useful tool for early prediction of the subsequent course of jaundice in healthy term newborns in Indian population. It may help to improve the management of newborns.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalPerinatology
Volume13
Issue number1
Publication statusPublished - 04-2012

Fingerprint

Neonatal Hyperbilirubinemia
Fetal Blood
Bilirubin
Prospective Studies
Hyperbilirubinemia
Umbilical Cord
Newborn Infant
Jaundice
Serum
Blood Group Antigens
Mothers
Coombs Test
Birth Order
Phototherapy
Apgar Score
ROC Curve
Population
Gestational Age

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Cite this

@article{235514e0dabf486b86a8634084406cbc,
title = "Cord blood bilirubin level as an early predictor of neonatal hyperbilirubinemia - A hospital-based prospective study",
abstract = "Background: Neonatal hyperbilirubinemia, a condition characterized by elevated bilirubin level in blood, is a common, complicated, and controversial clinical problem. The American Academy of Pediatrics (AAP) recommends a follow-up visit, after 2 to 3 days of birth, to detect significant jaundice in all newborns discharged within 48 hours of delivery. The present study was carried out to evaluate cord blood bilirubin levels as an early predictor of neonatal hyperbilirubinemia. Methods: The study group consisted of 500 term, appropriate for gestational age (AGA) neonates with an Apgar score of ≥7. Total bilirubin of ≥15 mg/dL was defined as significant hyperbilirubinemia. Umbilical cord serum bilirubin (UCSB) was estimated and followed up daily for evidence of neonatal hyperbilirubinemia up to 5 postnatal days. Prevalence of hyperbilirubinemia was found to be 14{\%} in the study population. In case of clinical jaundice presenting before 5 days, serum bilirubin level was estimated on the day of detection. Values of bilirubin on fifth day were related with that of cord blood bilirubin. Blood groups of both mothers and newborns were evaluated. Direct Coomb's test was done in presence of ABO incompatibility. Data were analyzed using chi-square, and receiver operating characteristics (ROC) curve. Results: Mean UCSB was reported to be 1.56 ± 0.70 mg/dL. There was a significant association between route of delivery, birth order, and hyperbilirubinemia requiring phototherapy (P<.005). Using UCSB level of 31.9 mg/dL, hyperbilirubinemia could be predicted with sensitivity of 90{\%} and specificity of 82.55{\%} and positive predictive value of 45.65{\%} and negative predictive value of 98.07{\%}. There was no significant association found between the mothers' blood groups and increased risk of hyperbilirubinemia in neonates in this study. Conclusion: This study suggests that the measurement of UCSB is a useful tool for early prediction of the subsequent course of jaundice in healthy term newborns in Indian population. It may help to improve the management of newborns.",
author = "Vikram Singhal and Nutan Kamath and Baliga, {B. S.} and B. Unnikrishnan",
year = "2012",
month = "4",
language = "English",
volume = "13",
pages = "1--8",
journal = "Perinatology",
issn = "0972-2408",
publisher = "Prism Books Pvt Ltd",
number = "1",

}

Cord blood bilirubin level as an early predictor of neonatal hyperbilirubinemia - A hospital-based prospective study. / Singhal, Vikram; Kamath, Nutan; Baliga, B. S.; Unnikrishnan, B.

In: Perinatology, Vol. 13, No. 1, 04.2012, p. 1-8.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cord blood bilirubin level as an early predictor of neonatal hyperbilirubinemia - A hospital-based prospective study

AU - Singhal, Vikram

AU - Kamath, Nutan

AU - Baliga, B. S.

AU - Unnikrishnan, B.

PY - 2012/4

Y1 - 2012/4

N2 - Background: Neonatal hyperbilirubinemia, a condition characterized by elevated bilirubin level in blood, is a common, complicated, and controversial clinical problem. The American Academy of Pediatrics (AAP) recommends a follow-up visit, after 2 to 3 days of birth, to detect significant jaundice in all newborns discharged within 48 hours of delivery. The present study was carried out to evaluate cord blood bilirubin levels as an early predictor of neonatal hyperbilirubinemia. Methods: The study group consisted of 500 term, appropriate for gestational age (AGA) neonates with an Apgar score of ≥7. Total bilirubin of ≥15 mg/dL was defined as significant hyperbilirubinemia. Umbilical cord serum bilirubin (UCSB) was estimated and followed up daily for evidence of neonatal hyperbilirubinemia up to 5 postnatal days. Prevalence of hyperbilirubinemia was found to be 14% in the study population. In case of clinical jaundice presenting before 5 days, serum bilirubin level was estimated on the day of detection. Values of bilirubin on fifth day were related with that of cord blood bilirubin. Blood groups of both mothers and newborns were evaluated. Direct Coomb's test was done in presence of ABO incompatibility. Data were analyzed using chi-square, and receiver operating characteristics (ROC) curve. Results: Mean UCSB was reported to be 1.56 ± 0.70 mg/dL. There was a significant association between route of delivery, birth order, and hyperbilirubinemia requiring phototherapy (P<.005). Using UCSB level of 31.9 mg/dL, hyperbilirubinemia could be predicted with sensitivity of 90% and specificity of 82.55% and positive predictive value of 45.65% and negative predictive value of 98.07%. There was no significant association found between the mothers' blood groups and increased risk of hyperbilirubinemia in neonates in this study. Conclusion: This study suggests that the measurement of UCSB is a useful tool for early prediction of the subsequent course of jaundice in healthy term newborns in Indian population. It may help to improve the management of newborns.

AB - Background: Neonatal hyperbilirubinemia, a condition characterized by elevated bilirubin level in blood, is a common, complicated, and controversial clinical problem. The American Academy of Pediatrics (AAP) recommends a follow-up visit, after 2 to 3 days of birth, to detect significant jaundice in all newborns discharged within 48 hours of delivery. The present study was carried out to evaluate cord blood bilirubin levels as an early predictor of neonatal hyperbilirubinemia. Methods: The study group consisted of 500 term, appropriate for gestational age (AGA) neonates with an Apgar score of ≥7. Total bilirubin of ≥15 mg/dL was defined as significant hyperbilirubinemia. Umbilical cord serum bilirubin (UCSB) was estimated and followed up daily for evidence of neonatal hyperbilirubinemia up to 5 postnatal days. Prevalence of hyperbilirubinemia was found to be 14% in the study population. In case of clinical jaundice presenting before 5 days, serum bilirubin level was estimated on the day of detection. Values of bilirubin on fifth day were related with that of cord blood bilirubin. Blood groups of both mothers and newborns were evaluated. Direct Coomb's test was done in presence of ABO incompatibility. Data were analyzed using chi-square, and receiver operating characteristics (ROC) curve. Results: Mean UCSB was reported to be 1.56 ± 0.70 mg/dL. There was a significant association between route of delivery, birth order, and hyperbilirubinemia requiring phototherapy (P<.005). Using UCSB level of 31.9 mg/dL, hyperbilirubinemia could be predicted with sensitivity of 90% and specificity of 82.55% and positive predictive value of 45.65% and negative predictive value of 98.07%. There was no significant association found between the mothers' blood groups and increased risk of hyperbilirubinemia in neonates in this study. Conclusion: This study suggests that the measurement of UCSB is a useful tool for early prediction of the subsequent course of jaundice in healthy term newborns in Indian population. It may help to improve the management of newborns.

UR - http://www.scopus.com/inward/record.url?scp=84866627603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866627603&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 1

EP - 8

JO - Perinatology

JF - Perinatology

SN - 0972-2408

IS - 1

ER -